Article
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal…
bioRxiv · 2021 · Anika Reifschneider
Key facts
| Title | Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathology |
|---|---|
| First author | Anika Reifschneider |
| Journal | bioRxiv |
| Published | Jul 10, 2021 |
| DOI | 10.1101/2021.07.08.451574 |
| Devices mentioned | 211731, K042152, K062324, K123717, K133972, K142003, K150650, K152294, K161032, K170858, K191495, K192440 and 18 more |
| Product codes mentioned | CDT, CEO, CFN, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DFZ and 19 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1